1. Delocalized quinolinium-macrocyclic peptides, an atypical chemotype for CNS penetration
   Valeria Pingitore et al, 2024, Science Advances CrossRef
2. Metabolic profile of Rhizoma coptidis in human plasma determined using ultra‐high‐performance liquid chromatography coupled with high‐resolution mass spectrometry
   Qing‐Shan Zhang et al, 2018, Rapid Communications in Mass Spectrometry CrossRef
3. Comparison of Pinoresinol and its Diglucoside on their ADME Properties and Vasorelaxant Effects on Phenylephrine-Induced Model
   Yiqiong Pu et al, 2021, Frontiers in Pharmacology CrossRef
4. Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer’s disease analyzed by network pharmacology and molecular docking prediction
   Shishuai Wang et al, 2022, Frontiers in Aging Neuroscience CrossRef
5. Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents
   Jichao Chen et al, 2022, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
6. Palmatine, a Bioactive Protoberberine Alkaloid Isolated from Berberis cretica, Inhibits the Growth of Human Estrogen Receptor-Positive Breast Cancer Cells and Acts Synergistically and Additively with Doxorubicin
   Aneta Grabarska et al, 2021, Molecules CrossRef
7. 9-Hydroxy-8-oxypalmatine, a novel liver-mediated oxymetabolite of palmatine, alleviates hyperuricemia and kidney inflammation in hyperuricemic mice
   Xiaoyan Wu et al, 2024, Journal of Ethnopharmacology CrossRef
8. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties
   Teruo Murakami et al, 2023, Expert Opinion on Drug Metabolism & Toxicology CrossRef
9. Antitumor efficiency of the natural alkaloid berberine complexed with C60 fullerene in Lewis lung carcinoma in vitro and in vivo
   Anna Grebinyk et al, 2021, Cancer Nanotechnology CrossRef
10. Identification of components and metabolites in plasma of type 2 diabetic rat after oral administration of Jiao‐Tai‐Wan using ultra‐performance liquid chromatography/quadrupole time‐of‐flight mass spectrometry
    Zhihui Li et al, 2020, Journal of Separation Science CrossRef
11. In Vitro Study of the Metabolic Characteristics of Eight Isoquinoline Alkaloids from Natural Plants in Rat Gut Microbiota
    Chi-Yu He et al, 2017, Molecules CrossRef
12. Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
    Xiaopeng Ai et al, 2021, Frontiers in Pharmacology CrossRef
13. Jatrorrhizine: A Review of Sources, Pharmacology, Pharmacokinetics and Toxicity
    Furong Zhong et al, 2022, Frontiers in Pharmacology CrossRef
14. Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review
    Qian Ran et al, 2019, Frontiers in Pharmacology CrossRef
15. Characterization and Pharmacokinetic Assessment of a New Berberine Formulation with Enhanced Absorption In Vitro and in Human Volunteers
    Julia Solnier et al, 2023, Pharmaceutics CrossRef
16. Palmatine: A review of pharmacological properties and pharmacokinetics
    Dominik Tarabasz et al, 2020, Phytotherapy Research CrossRef
17. Protoberberine alkaloids: A review of the gastroprotective effects, pharmacokinetics, and toxicity
    Ze-Dong Xiang et al, 2024, Phytomedicine CrossRef
18. Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity
    Yi-ting Zhang et al, 2019, Acta Pharmacologica Sinica CrossRef
19. Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs
    Wei Xiong et al, 2021, Carbohydrate Polymers CrossRef
20. Physicochemical properties and biological activities of new berberine-based salts with syringic acid as well as 3,5-dimethoxybenzoic acid as anions: Effect of temperature, concentration and anion
    Zhenning Yan et al, 2024, Journal of Molecular Liquids CrossRef
21. Studies on synthesis, physicochemical properties, biological activities of two novel berberine-based salts with DL-mandelate and cinnamate anions
    Huanhuan Lu et al, 2023, Journal of Molecular Structure CrossRef
22. The metabolism of berberine and its contribution to the pharmacological effects
    Kun Wang et al, 2017, Drug Metabolism Reviews CrossRef
23. Targeting Alzheimer’s Disease: Evaluating the Efficacy of C-1 Functionalized N-Aryl-Tetrahydroisoquinolines as Cholinergic Enzyme Inhibitors and Promising Therapeutic Candidates
    Dunja Jovanović et al, 2024, International Journal of Molecular Sciences CrossRef
24. Evaluation of anti-tumor activity of molybdenum disulfide nanoflowers per se and in combination with berberine against mammary gland cancer in rats
    Amna Roheel et al, 2024, Journal of Nanoparticle Research CrossRef
25. 13-Methylpalmatine improves myocardial infarction injury by inhibiting CHOP-mediated cross-talk between endoplasmic reticulum and mitochondria
    Zefeng Jiang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
26. Botanical Sources, Pharmacokinetics, and Therapeutic Efficacy of Palmatine and Its Derivatives in the Management of Cancer: A Comprehensive Mechanistic Analysis
    Most. Israt Jahan Oni et al, 2024, Journal of Food Biochemistry CrossRef
27. Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization
    Solomon Habtemariam, 2020, Molecules CrossRef
28. Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation
    Shelby L. Johnson et al, 2019, Metabolites CrossRef
29. Selenium-Methionine-Folic Acid Nanoparticles (SeMetFa NPs) and Its In Vivo Efficacy Against Rheumatoid Arthritis
    Vrundali Shinde et al, 2024, Biological Trace Element Research CrossRef